Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Select Medical Holdings (SEM) Long-Term Debt Repayments (2018 - 2025)

Select Medical Holdings (SEM) has disclosed Long-Term Debt Repayments for 7 consecutive years, with $1.3 billion as the latest value for Q4 2025.

  • On a quarterly basis, Long-Term Debt Repayments rose 550.79% to $1.3 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $1.3 billion, a 8.48% decrease, with the full-year FY2025 number at $1.3 billion, down 8.48% from a year prior.
  • Long-Term Debt Repayments was $1.3 billion for Q4 2025 at Select Medical Holdings, up from $9.3 million in the prior quarter.
  • In the past five years, Long-Term Debt Repayments ranged from a high of $1.3 billion in Q4 2025 to a low of -$496.7 million in Q3 2023.
  • A 5-year average of $256.4 million and a median of $105.2 million in 2021 define the central range for Long-Term Debt Repayments.
  • Biggest YoY gain for Long-Term Debt Repayments was 2288.74% in 2022; the steepest drop was 2184.41% in 2022.
  • Select Medical Holdings' Long-Term Debt Repayments stood at -$15.3 million in 2021, then soared by 5388.2% to $809.8 million in 2022, then rose by 27.4% to $1.0 billion in 2023, then plummeted by 81.1% to $195.0 million in 2024, then surged by 550.79% to $1.3 billion in 2025.
  • Per Business Quant, the three most recent readings for SEM's Long-Term Debt Repayments are $1.3 billion (Q4 2025), $9.3 million (Q3 2025), and -$313.3 million (Q2 2025).